ReviewInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2025
National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutions.
Review in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Non-Invasive Diagnosis of Early Breast Cancer: Current and Emerging Liquid Biopsy Biomarkers.Cancers · 2026Review
- National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutions.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Breast cancer represents a significant burden of disease for women across the globe. Screening has been demonstrated to decrease breast cancer-related mortality. However, many nations do not have population breast cancer screening programs, which are key to early detection and can decrease mortality rates. In 2024, the International Federation of Gynecology and Obstetrics (FIGO) established the Committee on Breast Health to raise awareness about breast disease, advocate for improved prevention and treatment, and promote best practices. This manuscript aims to review national policies in screening and early detection across 7 of the countries represented in the FIGO Committee on Breast Health: Chile, Germany, India, Mexico, the Philippines, Senegal, and the United States. Policies for population screening for breast cancer are reviewed and compared across countries, as well as efforts in risk stratification. A framework for addressing population screening for breast cancer is also proposed that acknowledges resource and infrastructure limitations across nations. These efforts represent a critical step in addressing breast cancer-related mortality worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.